Should You Invest in Stevanato Group Spa (STVN) Now?

Stevanato Group Spa (NYSE: STVN) has a higher price-to-earnings ratio of 35.34x compared to its average ratio, The 36-month beta value for STVN is at 0.74. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”

The public float for STVN is 49.48M, and currently, shorts hold a 4.79% of that float. The average trading volume for STVN on May 09, 2024 was 400.37K shares.

STVN) stock’s latest price update

Stevanato Group Spa (NYSE: STVN)’s stock price has decreased by -22.05 compared to its previous closing price of 26.91. However, the company has seen a -21.76% decrease in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-05-02 that Investors interested in stocks from the Medical – Drugs sector have probably already heard of USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two companies is the best option for those looking for undervalued stocks?

STVN’s Market Performance

STVN’s stock has fallen by -21.76% in the past week, with a monthly drop of -27.67% and a quarterly drop of -37.81%. The volatility ratio for the week is 5.98% while the volatility levels for the last 30 days are 4.45% for Stevanato Group Spa The simple moving average for the last 20 days is -24.43% for STVN stock, with a simple moving average of -29.57% for the last 200 days.

Analysts’ Opinion of STVN

Jefferies, on the other hand, stated in their research note that they expect to see STVN reach a price target of $29, previously predicting the price at $39. The rating they have provided for STVN stocks is “Hold” according to the report published on November 01st, 2023.

Stephens gave a rating of “Overweight” to STVN, setting the target price at $33 in the report published on September 26th of the previous year.

STVN Trading at -28.51% from the 50-Day Moving Average

After a stumble in the market that brought STVN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.22% of loss for the given period.

Volatility was left at 4.45%, however, over the last 30 days, the volatility rate increased by 5.98%, as shares sank -30.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -34.91% lower at present.

During the last 5 trading sessions, STVN fell by -24.93%, which changed the moving average for the period of 200-days by -38.44% in comparison to the 20-day moving average, which settled at $27.31. In addition, Stevanato Group Spa saw -23.14% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for STVN

Current profitability levels for the company are sitting at:

  • 0.18 for the present operating margin
  • 0.31 for the gross margin

The net margin for Stevanato Group Spa stands at 0.14. The total capital return value is set at 0.13. Equity return is now at value 13.61, with 7.76 for asset returns.

Based on Stevanato Group Spa (STVN), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at 0.27. The debt to equity ratio resting at 0.34. The interest coverage ratio of the stock is 12.75.

Currently, EBITDA for the company is 263.27 million with net debt to EBITDA at 1.34. When we switch over and look at the enterprise to sales, we see a ratio of 5.99. The receivables turnover for the company is 2.06for trailing twelve months and the total asset turnover is 0.52. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.50.

Conclusion

In conclusion, Stevanato Group Spa (STVN) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts